The framework was never the constraint

Something has been bugging me for some time. I see a lot of talking about CSA like it changed everything. It did not.

Twenty-five years of validation projects across pharma and med device. My honest read: Computer Software Assurance is old wine in a new bottle. And the industry is drinking it like it is vintage.

Here is what CSA touts: a risk-based approach, critical thinking over scripted testing, focusing effort where it matters. Sound familiar? It should. GAMP said this in 2008. PIC/S PI 011-3 said it before that. Regulators and industry associations have issued guidance to help industry interpret relevant regulations for decades. The principles of risk-based validation have been around for a long time.

The overproduction of documentation, the 400-page protocols for off-the-shelf SaaS, the IQ/OQ/PQ packages nobody reads: none of that was ever required by the existing frameworks. It was a cultural habit. A risk-averse interpretation of guidance that always gave you permission to do less.

CSA did not fix that culture. It rebranded the permission slip.

There is also a scope problem that rarely gets mentioned. The FDA CSA guidance is primarily directed at manufacturers of medical devices. Apply it uncritically to a GMP pharma environment and you may already be in contradiction with existing EU, US and other global regulations and other applicable guidance. The risk is real.

I am not saying the CSA framing is useless. It can be an entry point. But treating it as a breakthrough rather than a restatement at best means you are solving the symptom, not the cause.

The cause is that many organizations validate to satisfy auditors, not to manage risk. That has been true through years of guidance revision.

The framework was never the constraint. The thinking was.

If you want to actually improve, start by going back to GAMP 5 SE. Read PI 011-3. The answers were always there. They just required more judgement than a template.